Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancer.

PLoS One · 2015 · PMC4370816 · PMID 25799154

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In this cohort, C4d levels tended to be higher in BAL fluids from small cell lung cancer (SCLC) patients or former smokers, although the differences did not reach statistical significance ( Table 1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.